Eterna Therapeutics (ERNA)
Search documents
Eterna Therapeutics (ERNA) - 2021 Q1 - Quarterly Report
2021-05-17 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _____________ Commission file number: 001-11460 Brooklyn ImmunoTherapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware ...
Eterna Therapeutics (ERNA) - 2020 Q4 - Annual Report
2021-03-11 22:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 Commission File Number 1-11460 | --- | --- | --- | --- | |---------------------------------------|--------------------------------------------|--------------------------|-----------------------------------| | | NTN (Exact name of registrant as | Buzztime, Inc. specified | in its charter) | | Delaware ...
Eterna Therapeutics (ERNA) - 2020 Q3 - Quarterly Report
2020-11-13 22:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American Emerging growth company [ ] FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) DELAWARE 31-1103425 (State of incorporation) ( ...
Eterna Therapeutics (ERNA) - 2020 Q2 - Quarterly Report
2020-08-07 22:47
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American Emerging growth company [ ] FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) DELAWARE 31-1103425 (State of incorporation) (I.R.S ...
Eterna Therapeutics (ERNA) - 2020 Q1 - Quarterly Report
2020-05-20 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American Non-accelerated filer [X] Smaller reporting company [X] Emerging growth company [ ] FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its cha ...
Eterna Therapeutics (ERNA) - 2020 Q1 - Earnings Call Transcript
2020-05-19 23:15
NTN Buzztime, Inc. (NTN) Q1 2020 Results Conference Call May 19, 2020 4:30 PM ET Company Participants Kirsten Chapman - LHA, IR Allen Wolf - CEO Conference Call Participants Operator Ladies and gentlemen, thank you for standing by and welcome to the NTN Buzztime Earnings Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your host for today, Kirsten Cha ...
Eterna Therapeutics (ERNA) - 2019 Q4 - Annual Report
2020-03-19 20:18
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 Commission File Number 1-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) Delaware 31-1103425 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 1800 Aston Avenue, Suite 100 Carlsbad, California 92008 (Address of Principa ...
Eterna Therapeutics (ERNA) - 2019 Q4 - Earnings Call Transcript
2020-03-17 23:48
NTN Buzztime, Inc. (NTN) Q4 2019 Earnings Conference Call March 17, 2020 4:30 PM ET Company Participants Kirsten Chapman - LHA Investor Relations Allen Wolff - CEO Sandra Gurrola - SVP of Finance Operator Ladies and gentlemen, thank you for standing by and welcome to the Q4 2019 NTN Buzztime Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today’s conference is being recorded. I would now like to turn the conference over to your host, Ms. Kirste ...
Eterna Therapeutics (ERNA) - 2019 Q3 - Earnings Call Transcript
2019-11-03 08:33
NTN Buzztime, Inc. (NTN) Q3 2019 Earnings Conference Call October 30, 2019 4:30 PM ET Company Participants Kirsten Chapman - LHA, IR Allen Wolff - Interim CEO Sandra Gurrola - SVP of Finance Conference Call Participants Operator Operator Good afternoon, ladies and gentlemen, and welcome to the NTN Buzztime Third Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the conf ...
Eterna Therapeutics (ERNA) - 2019 Q3 - Quarterly Report
2019-11-01 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American Emerging growth company [ ] FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) 1800 ASTON AVENUE, SUITE 100, CARLSBAD, CALIFO ...